Jul 28, 2026 02:36AM
Jul 27, 2026 07:02AM
Jul 1, 2026 09:03AM
Jun 26, 2026 06:41AM
Jun 17, 2026 08:01AM
Jun 5, 2026 06:09AM
Jun 3, 2026 08:01AM Gossamer Bio reports 90.5% participation in convertible note exchange
May 18, 2026 07:51AM
May 18, 2026 07:06AM
Mar 23, 2026 03:12AM
Mar 17, 2026 04:13PM
Feb 24, 2026 07:03AM
Feb 24, 2026 04:34AM
Feb 24, 2026 12:43AM Leerink Partners Downgrades Gossamer Bio Inc. (GOSS) to Market Perform
Feb 23, 2026 07:59AM
Feb 4, 2026 05:05AM
Feb 2, 2026 10:49AM
Jan 28, 2026 04:23PM
Jan 22, 2026 07:45AM
Jan 22, 2026 06:42AM
Nov 13, 2025 07:29AM Gossamer Bio's (GOSS) Seralitinib Data Likely Comes Out by Feb - Cantor Fitzgerald
Nov 5, 2025 05:49PM
Sep 26, 2025 04:45AM
Sep 16, 2025 06:55AM
Sep 15, 2025 02:00AM
Sep 11, 2025 10:00AM
Sep 11, 2025 06:49AM
Sep 10, 2025 04:17AM UBS Upgrades Gossamer Bio Inc. (GOSS) to Buy
Aug 19, 2025 06:39AM
May 16, 2025 06:45AM
May 15, 2025 04:02PM
Mar 18, 2025 06:43AM
Mar 13, 2025 05:34PM
Feb 3, 2025 07:01AM
Jan 3, 2025 08:23AM Piper Sandler Explores Direct and Indirect Catalysts for Selected Biotechnology Companies
Nov 8, 2024 06:31AM
Sep 18, 2024 06:43AM
Sep 12, 2024 07:43AM
Sep 7, 2024 08:00PM
Aug 30, 2024 06:54AM
Aug 12, 2024 04:22PM
Jul 15, 2024 08:44AM Piper Sandler Reiterates Overweight Rating on Gossamer Bio Inc. (GOSS)

442,126 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All